Statins and Risk of Myocardial Infarction in Real Life in France
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00679575 |
Recruitment Status
:
Completed
First Posted
: May 19, 2008
Last Update Posted
: December 8, 2010
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Myocardial Infarction |
Study Type : | Observational |
Actual Enrollment : | 13171 participants |
Observational Model: | Case Control |
Time Perspective: | Prospective |
Official Title: | Statins and Risk of Myocardial Infarction in Real Life in France |
Study Start Date : | March 2007 |
Actual Primary Completion Date : | November 2010 |
Actual Study Completion Date : | November 2010 |
Group/Cohort |
---|
1
Cases : Patients with a first myocardial infarction
|
2
Referents : Patients recruited by a GP during a routine consultation
|
- Assess the impact of the different statins (molecules) usage on the risk of having a first myocardial infarction in a real life situation in France [ Time Frame: in 2011 ]
- Assess the interaction between statin treatment and risk factors such as cholesterol, age, gender, tobacco, alcohol, co-prescriptions, co-morbidities [ Time Frame: in 2011 ]
- Assess the populational impact of statins usage on the risk of having a first myocardial infarction [ Time Frame: in 2011 ]
- Assess the risk of having a first myocardial infarction according to high and low dosages of statins [ Time Frame: in 2011 ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- Patients can speak French or English
- Patients can be interviewed by telephone
- Place of usual residence in the area of recruitment
Exclusion Criteria:
- Patients refusing to participate in the study
- Patients who cannot be reached by telephone
- Previous history of myocardial infarction

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00679575

France | |
Research Site | |
Ambilly, France | |
Research Site | |
Angers, France | |
Research Site | |
Arles, France | |
Research Site | |
Bagnols sur Ceze, France | |
Research Site | |
Bayonne, France | |
Research Site | |
Beziers, France | |
Research Site | |
Boulogne sur mer, France | |
Research Site | |
Bourgoin Jallieu, France | |
Research Site | |
Bron, France | |
Research Site | |
Cambo les Bains, France | |
Research Site | |
Cenon, France | |
Research Site | |
Chateauroux, France | |
Research Site | |
Clermont Ferrand, France | |
Research Site | |
Colmar, France | |
Research Site | |
Crest, France | |
Research Site | |
Dijon, France | |
Research Site | |
Draguignan, France | |
Research Site | |
Eaubonne, France | |
Research Site | |
Firminy, France | |
Research Site | |
Forbach, France | |
Research Site | |
Frejus, France | |
Research Site | |
Gleize, France | |
Research Site | |
Grasse, France | |
Research Site | |
Gueret, France | |
Research Site | |
La Rochelle, France | |
Research Site | |
Langres, France | |
Research Site | |
Laon, France | |
Research Site | |
Le Coudray, France | |
Research Site | |
Le Mans, France | |
Research Site | |
Le Puy en Velay, France | |
Research Site | |
Mayenne, France | |
Research Site | |
Millau, France | |
Research Site | |
Montelimar, France | |
Research Site | |
Montfermeil, France | |
Research Site | |
Montpellier, France | |
Research Site | |
Nimes, France | |
Research Site | |
Orange, France | |
Research Site | |
Orleans, France | |
Research Site | |
Paris, France | |
Research Site | |
Pau, France | |
Research Site | |
Perpignan, France | |
Research Site | |
Puilboreau, France | |
Research Site | |
Rueil Malmaison, France | |
Research Site | |
Rumilly, France | |
Research Site | |
Saint Jean des Verges, France | |
Research Site | |
Sallanches, France | |
Research Site | |
Salon de provence, France | |
Research Site | |
Sens, France | |
Research Site | |
St Amand Monrond, France | |
Research Site | |
St-Esteve, France | |
Research Site | |
Thonon les Bains, France | |
Research Site | |
Toulouse, France | |
Research Site | |
Tours, France | |
Research Site | |
Tulles, France | |
Research Site | |
Valence, France | |
Research Site | |
Villefranche de Rouergue, France |
Study Chair: | Lucien Abenhaim | LA-SER29, rue du Faubourg Saint-Jacques75014 Paris |
Responsible Party: | Russel Esterline, AstraZeneca |
ClinicalTrials.gov Identifier: | NCT00679575 History of Changes |
Other Study ID Numbers: |
NIS-CFR-CRE-2007/1 |
First Posted: | May 19, 2008 Key Record Dates |
Last Update Posted: | December 8, 2010 |
Last Verified: | December 2010 |
Keywords provided by AstraZeneca:
statins myocardial infarction case-referent study France |
Additional relevant MeSH terms:
Infarction Myocardial Infarction Ischemia Pathologic Processes Necrosis Myocardial Ischemia Heart Diseases Cardiovascular Diseases |
Vascular Diseases Hydroxymethylglutaryl-CoA Reductase Inhibitors Anticholesteremic Agents Hypolipidemic Agents Antimetabolites Molecular Mechanisms of Pharmacological Action Enzyme Inhibitors Lipid Regulating Agents |